Published in Br J Pharmacol on May 01, 2000
Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol (2012) 1.31
Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br J Pharmacol (2000) 1.09
Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice. Br J Pharmacol (2002) 0.93
Nitroglycerin drives endothelial nitric oxide synthase activation via the phosphatidylinositol 3-kinase/protein kinase B pathway. Free Radic Biol Med (2011) 0.88
The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction. Front Immunol (2013) 0.87
Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice. BMC Cardiovasc Disord (2006) 0.87
Arginase II inhibition prevents nitrate tolerance. Br J Pharmacol (2012) 0.85
Effects of chronic in vivo administration of nitroglycerine on ACh-induced endothelium-dependent relaxation in rabbit cerebral arteries. Br J Pharmacol (2007) 0.83
Nitrate tolerance and the links with endothelial dysfunction and oxidative stress. Br J Clin Pharmacol (2003) 0.83
Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries. Br J Pharmacol (2007) 0.82
Chronic nitroglycerine administration reduces endothelial nitric oxide production in rabbit mesenteric resistance artery. Br J Pharmacol (2005) 0.81
Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies. Heart Fail Rev (2002) 0.81
Arginine and nitrate tolerance. Br J Pharmacol (2000) 0.79
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 4.50
Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol (1988) 3.66
Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest (1986) 3.59
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest (1995) 2.94
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem (1997) 1.97
Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett (1991) 1.96
Nitrate therapy for stable angina pectoris. N Engl J Med (1998) 1.80
L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem Biophys Res Commun (1989) 1.76
Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res (1995) 1.76
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol (1999) 1.74
Endothelial function in chronic congestive heart failure. Am J Cardiol (1992) 1.69
Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun (1991) 1.64
Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther (1995) 1.40
Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun (1989) 1.29
Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol (1987) 1.27
Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J Pharmacol Exp Ther (1990) 1.24
Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1992) 1.16
Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production. Am J Physiol Cell Physiol (2000) 1.09
Contribution of nitric oxide to the endothelium-dependent hyperpolarization in rat aorta. J Physiol (1994) 1.05
Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity. Nitric Oxide (1997) 0.97
L-arginine-dependent vascular smooth muscle relaxation and cGMP formation. Am J Physiol (1990) 0.91
Human endothelial cells bioactivate organic nitrates to nitric oxide: implications for the reinforcement of endothelial defence mechanisms. Eur J Clin Invest (1995) 0.87
Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency. Circulation (1986) 0.87
Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings. Evidence for two mechanisms of action. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.87
Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. Free Radic Biol Med (1996) 0.85
Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol (1989) 0.84
Nitroglycerin-inhibited whole blood aggregation is partially mediated by calcitonin gene-related peptide -- a neurogenic mechanism. Br J Pharmacol (1997) 0.81
Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast. Eur J Pharmacol (1993) 0.81
Tolerance induction by transdermal glyceryl trinitrate in rats. Eur J Pharmacol (1999) 0.80
Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: reversal by L-arginine. Biochem Biophys Res Commun (1992) 0.79
Endothelium-dependent relaxation of rat thoracic aorta by amrinone-induced nitric oxide release. Eur Heart J (1996) 0.79
Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats. Eur J Pharmacol (1993) 0.78
Studies on the biphasic relaxant curve of glyceryl trinitrate in rat aorta: role of GTN metabolites. Clin Exp Pharmacol Physiol (1989) 0.77
Demonstration of a high affinity component of glyceryl trinitrate induced vasodilatation in the bovine mesenteric artery. J Cyclic Nucleotide Protein Phosphor Res (1988) 0.77
Influence of vascular tolerance to nitroglycerin on endothelium-dependent relaxation. Arch Int Pharmacodyn Ther (1987) 0.77
Relaxation of bovine mesenteric artery induced by glyceryl trinitrate is attenuated by pertussis toxin. Pharmacol Toxicol (1988) 0.77
Zearalenone production by Fusarium species. Appl Microbiol (1970) 2.83
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem (1999) 2.18
Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res (1995) 1.94
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol (1999) 1.74
Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci (2001) 1.57
VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.53
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J (2001) 1.44
Nifedipine GITS (gastrointestinal therapeutic system) bezoar. Arch Intern Med (1991) 1.38
Retracted Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J (2007) 1.34
Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol (2012) 1.31
Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther (1987) 1.19
TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci (2001) 1.16
Microglial cells invade the outer retina as photoreceptors degenerate in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci (1996) 1.14
Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia (1998) 1.13
Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia (2004) 1.12
VEGF-induced permeability increase is mediated by caveolae. Invest Ophthalmol Vis Sci (1999) 1.11
Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production. Am J Physiol Cell Physiol (2000) 1.09
Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br J Pharmacol (2000) 1.09
Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem (2000) 1.08
Second report on chicken genes and chromosomes 2005. Cytogenet Genome Res (2005) 1.05
New process for T-2 toxin production. Appl Environ Microbiol (1982) 1.04
Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br J Pharmacol (1996) 1.04
Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol (2007) 1.04
Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J (1999) 1.03
Photoreceptor-specific activity of the human interphotoreceptor retinoid-binding protein (IRBP) promoter in transgenic mice. Exp Eye Res (1992) 0.98
Astrocytes modulate retinal vasculogenesis: effects on fibronectin expression. J Cell Sci (1994) 0.96
Astrocytes modulate retinal vasculogenesis: effects on endothelial cell differentiation. Glia (1995) 0.96
Angiostatic role of astrocytes: suppression of vascular endothelial cell growth by TGF-beta and other inhibitory factor(s). Glia (1995) 0.95
Elastic fibers in the anulus fibrosus of the dog intervertebral disc. Acta Anat (Basel) (1984) 0.95
An improved method for isolation and culture of pigment epithelial cells from rat retina. Curr Eye Res (1991) 0.94
The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia (2012) 0.93
Cultured Müller cells have high levels of epidermal growth factor receptors. Invest Ophthalmol Vis Sci (1992) 0.92
Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. J Pharmacol Exp Ther (2003) 0.91
Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells. Biochem Biophys Res Commun (1998) 0.91
Certain norditerpenoid alkaloids and their cardiovascular action. J Nat Prod (1998) 0.90
Serum opens tight junctions and reduces ZO-1 protein in retinal epithelial cells. J Neurochem (1997) 0.90
Effect of chronic hypoxia on angiotensin-induced pulmonary vasoconstriction and converting enzyme activity in the rat. Proc Soc Exp Biol Med (1983) 0.90
Modulation of VEGF production by pH and glucose in retinal Müller cells. Curr Eye Res (1998) 0.89
Serum inhibits tight junction formation in cultured pigment epithelial cells. Invest Ophthalmol Vis Sci (1997) 0.89
Freeze-fracture study of filipin binding in photoreceptor outer segments and pigment epithelium of dystrophic and normal retinas. J Comp Neurol (1985) 0.86
Isolation and culture of retinal microglia. Curr Eye Res (1993) 0.86
alpha-Adrenergic blocking properties of quinine HCl. Eur J Pharmacol (1980) 0.85
Effect of diterpenoid alkaloids on cardiac sympathetic efferent and vagal afferent nerve activity. Eur J Pharmacol (1995) 0.84
Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats. J Hypertens (1987) 0.84
Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx. Br J Pharmacol (2010) 0.84
A quantitative study of intramembrane changes during cell junctional breakdown in the dystrophic rat retinal pigment epithelium. Exp Cell Res (1984) 0.83
Endothelial cell dysfunction in a model of oxidative stress. Med Sci Monit (2001) 0.83
Freeze-fracture quantitative comparison of rabbit corneal epithelial and endothelial membranes. Curr Eye Res (1985) 0.83
The role of substance P in myocardial dysfunction during ischemia and reperfusion. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.82
Local cardiac effects of substance P: roles of acetylcholine and noradrenaline. Br J Pharmacol (1995) 0.82
Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity. Eur J Pharmacol (1998) 0.82
Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes. Invest Ophthalmol Vis Sci (1986) 0.81
Lanthanum and freeze-fracture studies of retinal pigment epithelial cell junctions in the streptozotocin diabetic rat. Curr Eye Res (1985) 0.81
Redistribution of Na-K-ATPase in the dystrophic rat retinal pigment epithelium. J Neurocytol (1984) 0.80
The retinal microvasculature of spontaneously diabetic BB rats: structure and luminal surface properties. Microvasc Res (1990) 0.80
Effect of nitrite on endothelial function in isolated lung. Gen Pharmacol (2000) 0.80
Pigment epithelial cell changes precede vascular transformations in the dystrophic rat retina. Exp Eye Res (1991) 0.80
Biotechnology and the chicken B cell line DT40. Cytogenet Genome Res (2007) 0.79
Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity. Hypertension (1982) 0.79
HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro. J Pharmacol Exp Ther (1995) 0.78
Mechanisms of altered sodium excretion after preoptic hypothalamic lesions. Am J Physiol (1988) 0.78
Vascular and endothelial actions of inhibitors of substance P amidation. J Cardiovasc Pharmacol (2000) 0.78
Pharmacological studies of a new 4-aminosugar cardiac glycoside (ASI-222). J Pharmacol Exp Ther (1976) 0.78
Müller cell changes precede vascularization of the pigment epithelium in the dystrophic rat retina. Glia (1990) 0.78
Superior colliculus neurons which project to the cat lateral posterior nucleus have varying morphologies. J Comp Neurol (1981) 0.78
Retinal pigment epithelial cells from dystrophic rats form normal tight junctions in vitro. Invest Ophthalmol Vis Sci (1997) 0.78
Permeability of retinal pigment epithelial cell junctions in the dystrophic rat retina. Exp Eye Res (1983) 0.78
Amidative peptide processing and vascular function. Am J Physiol (1997) 0.77
Acute cardiovascular and autonomic effects of WR-2721: a radioprotective compound. Radiat Res (1975) 0.77
Vascular alpha-adrenergic blocking properties of quinidine. Eur J Pharmacol (1983) 0.77
Atherosclerosis and nitric oxide production. Circulation (2000) 0.77
Comparison of the effects of aminosugar cardiac glycosides with ouabain and digoxin on Na+, K+ -adenosine triphosphatase and cardiac contractile force. J Pharmacol Exp Ther (1978) 0.76
The superior colliculus neurons which project to the dorsal and ventral lateral geniculate nuclei in the cat. Exp Brain Res (1982) 0.75
Effect of anteroventral third ventricle lesions on vascular sodium-pump activity in two-kidney Goldblatt hypertension. Hypertension (1983) 0.75
Cardiovascular effects following clonidine microinjection into the nucleus tractus solitarii of the rat. Neuropharmacology (1980) 0.75
Mechanism of the pulmonary vasoconstrictor action of digoxin in the dog. J Cardiovasc Pharmacol (1985) 0.75
The mechanism of nitrous oxide-induced changes in pulmonary vascular resistance in a dog model of left atrial outflow obstruction. J Cardiothorac Anesth (1989) 0.75
Survival after congestive heart failure in Framingham Heart Study subjects. Circulation (1994) 0.75
The cardiovascular actions of WR-149,024 (1,18-diamino-7,13-diaza-9,10-dithiaoctadecane tetrahydrochloride). Br J Pharmacol (1972) 0.75
Adjustable dorsiflexion splint. Phys Ther (1972) 0.75
The cardiovascular response to digoxin in conscious dogs with left atrial obstruction. J Cardiothorac Anesth (1990) 0.75
Effect of a prostaglandin F2 alpha injection 96 hours after introduction of intact bulls on estrus and calving distribution of beef cows. J Anim Sci (1991) 0.75
Different patterns of autonomic nerve activity produced by a polar vs. a neutral cardiac glycoside. J Pharmacol Exp Ther (1990) 0.75
Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium. Biochem Pharmacol (1989) 0.75
Effects of sinoaortic denervation on the reflex actions of digoxin and a polar aminocardenolide. J Cardiovasc Pharmacol (1992) 0.75